PLTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Palantir Technologies Inc (PLTR) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst sentiment, and growth in AI-driven contracts make it a compelling opportunity despite some insider selling and neutral hedge fund activity.
The MACD is positive and expanding (1.14), suggesting bullish momentum. RSI is neutral at 52.546, indicating no overbought or oversold conditions. However, the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), signaling caution. Key support is at 127.726, and resistance is at 138.98. The pre-market price of 136.65 is near resistance, indicating potential upward movement.
Palantir's Q4 revenue surged 70% YoY to $1.4 billion, with net income up 670.39% YoY.
The company secured $4.3 billion in total contract value bookings in Q4, with a net dollar retention rate of 139%.
Analysts have upgraded the stock, citing strong growth, margin expansion, and attractive valuation.
Global AI spending is projected to reach $2.5 trillion by 2026, benefiting Palantir's AI-driven business model.
Insider selling has increased significantly (2150.93% over the last month).
Hedge funds remain neutral with no significant trading trends.
The stock's moving averages are bearish, indicating potential resistance to upward momentum.
In Q4 2025, Palantir's revenue increased by 70% YoY to $1.4 billion. Net income surged 670.39% YoY to $608.7 million, and EPS rose 700% YoY to 0.24. Gross margin improved to 84.65%, up 7.27% YoY, showcasing strong profitability and operational efficiency.
Recent analyst upgrades highlight Palantir's strong growth and attractive valuation. Mizuho upgraded the stock to Outperform, citing spectacular growth and margin expansion. Freedom Capital and Daiwa also upgraded the stock to Buy, emphasizing robust U.S. business growth and durable AI demand. However, BofA removed Palantir from its 'US 1 List,' and some analysts lowered price targets earlier in February due to valuation concerns.
